EEPD1

Across TCGA pan-cancer cohorts, EEPD1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated EEPD1 data layer compared with 26 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher EEPD1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated EEPD1 expression acts as an unfavorable survival marker, although some lineages such as LSCC and PDAC show a favorable association.

COAD, LSCC, and PDAC are the cancer types where EEPD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Quartile	III,IV	0.712	1.000	.027	24	view →
LSCC	DFS	Quartile	II,III,IV	1.000	0.577	.004	19	view →
PDAC	OS	Quartile	All	0.927	0.730	.019	9	view →
CCRCC	OS	Median	II,III,IV	0.958	0.750	.048	5	view →
LUAD	OS	Quartile	II,III,IV	0.314	0.810	.001	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

EEPD1–COAD (DFS)

Open the COAD breakdown →